Página principal > Resultados de la búsqueda: Hanke, Tomáš
  Consejos para la búsqueda
Búsqueda avanzada
Buscar colecciones:
Ordenar por: Mostrar resultados: Formato de visualización:
Resultados globales: 4 registros encontrados en 0.02 segundos.
Artículos, Encontrados 4 registros
Artículos Encontrados 4 registros  
1.
10 p, 868.0 KB Defining the HLA class I‐associated viral antigen repertoire from HIV‐1‐infected human cells / Ternette, Nicola (University of Oxford. The Jenner Institute, Nuffield Department of Medicine) ; Yang, Hongbing (University of Oxford. Nuffield Department of Medicine) ; Partridge, Thomas (University of Oxford. Nuffield Department of Medicine) ; Llano Montero, Anuska (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Cedeño, Samandhy (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Fischer, Roman (University of Oxford. Nuffield Department of Medicine) ; Charles, Philip D. (University of Oxford. Nuffield Department of Medicine) ; Dudek, Nadine L. (Monash University. Department of Biochemistry and Molecular Biology) ; Mothe, Beatriz (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Crespo, Manuel (Hospital de la Vall d'Hebron. HIV Unit) ; Fischer, William M. (Los Alamos National Laboratory. Group T-6, Theoretical Biology) ; Korber, Bette T. M. (Los Alamos National Laboratory. Group T-6, Theoretical Biology) ; Nielsen, Morten (Technical University of Denmark. Center for Biological Sequence Analysis) ; Borrow, Persephone (University of Oxford. Nuffield Department of Medicine) ; Purcell, Anthony W. (Monash University. Department of Biochemistry and Molecular Biology) ; Brander, Christian (Institució Catalana de Recerca i Estudis Avançats) ; Dorrell, Lucy (University of Oxford. The Jenner Institute, Nuffield Department of Medicine) ; Kessler, Benedikt M. (University of Oxford. Nuffield Department of Medicine) ; Hanke, Tomáš (University of Oxford. The Jenner Institute, Nuffield Department of Medicine) ; Universitat Autònoma de Barcelona
Recognition and eradication of infected cells by cytotoxic T lymphocytes is a key defense mechanism against intracellular pathogens. High‐throughput definition of HLA class I‐associated immunopeptidomes by mass spectrometry is an increasingly important analytical tool to advance our understanding of the induction of T‐cell responses against pathogens such as HIV‐1. [...]
2015 - 10.1002/eji.201545890
European Journal of Immunology, Vol. 46 (november 2015) , p. 60-69  
Registro completo - Creative Commons
2.
10 p, 763.1 KB Engineering new mycobacterial vaccine design for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCG / Saubi, Narcís (Universitat de Barcelona. Hospital Clínic. Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). AIDS Research Group) ; Gea-Mallorquí, Ester (Universitat de Barcelona. Hospital Clínic. Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). AIDS Research Group) ; Ferrer, Pau (Universitat Autònoma de Barcelona. Departament d'Enginyeria Química, Biològica i Ambiental) ; Hurtado, Carmen (Universitat de Barcelona. Hospital Clínic. Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). AIDS Research Group) ; Sánchez-Úbeda, Sara (Universitat de Barcelona. Hospital Clínic. Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). AIDS Research Group) ; Eto, Yoshiki (Universitat de Barcelona. Hospital Clínic. Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). AIDS Research Group) ; Gatell, Josep M (Universitat de Barcelona. Hospital Clínic. Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). AIDS Research Group) ; Hanke, Tomáš (University of Oxford. Weatherall Institute of Molecular Medicine. MRC Human Immunology Unit) ; Joseph, Joan (Universitat de Barcelona. Hospital Clínic. Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). AIDS Research Group)
In this study, we have engineered a new mycobacterial vaccine design by using an antibiotic-free plasmid selection system. We assembled a novel Escherichia coli (E. coli)-mycobacterial shuttle plasmid p2auxo. [...]
2014 - 10.1038/mtm.2014.17
Molecular therapy. Methods & clinical development, Vol. 1 (May 2014) , art. 14017  
Registro completo - Creative Commons
3.
22 p, 877.6 KB Identification of effective subdominant anti-HIV-1 CD8+ T cells within entire post-infection and post-vaccination immune responses / Hancock, Gemma (University of Oxford) ; Yang, Hongbing (University of Oxford) ; Yorke, Elisabeth (University of Toronto) ; Wainwright, Emma (Royal Berkshire NHS Foundation Trust (Reading, Gran Bretanya)) ; Bourne, Victoria (University of Oxford) ; Frisbee, Alyse (Duke University (Durham, Estats Units d'Amèrica)) ; Payne, Tamika L. (Duke University (Durham, Estats Units d'Amèrica)) ; Berrong, Mark (Duke University (Durham, Estats Units d'Amèrica)) ; Ferrari, Guido (Duke University (Durham, Estats Units d'Amèrica)) ; Chopera, Denis (University of Cape Town) ; Hanke, Tomas (University of Oxford) ; Mothe, Beatriz (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Brander, Christian (Hospital Germans Trias i Pujol) ; McElrath, M. Juliana (Fred Hutchinson Cancer Research Center (Seattle, Estats Units d'Amèrica)) ; McMichael, Andrew (University of Oxford) ; Goonetilleke, Nilu (University of North Carolina School of Medicine) ; Tomaras, Georgia D. (Duke University (North Carolina, Estats Units d'Amèrica)) ; Frahm, Nicole (Fred Hutchinson Cancer Research Center (Seattle, Estats Units d'Amèrica)) ; Dorrell, Lucy (University of Oxford)
Abstract. Defining the components of an HIV immunogen that could induce effective CD8+ T cell responses is critical to vaccine development. We addressed this question by investigating the viral targets of CD8+ T cells that potently inhibit HIV replication in vitro, as this is highly predictive of virus control in vivo. [...]
2015 - 10.1371/journal.ppat.1004658
PLoS Pathogens, Vol. 11 Núm. 2 (february 2015)  
Registro completo - Creative Commons
4.
23 p, 3.3 MB A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques / Mothe Pujadas, Beatriz (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Hu, Xintao (National Cancer Institute at Frederick (Frederick, Estats Units d'Amèrica)) ; Llano Montero, Anuska (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Rosati, Margherita (National Cancer Institute at Frederick (Frederick, Estats Units d'Amèrica)) ; Olvera, Alex (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Kulkarni, Viraj (National Cancer Institute at Frederick (Frederick, Estats Units d'Amèrica)) ; Valentin, Antonio (National Cancer Institute at Frederick (Frederick, Estats Units d'Amèrica)) ; Alicea, Cándido (National Cancer Institute at Frederick (Frederick, Estats Units d'Amèrica)) ; Pilkington, Guy R. (National Cancer Institute at Frederick (Frederick, Estats Units d'Amèrica)) ; Sardesai, Niranjan Y. (Inovio Pharmaceuticals) ; Rocafort, Muntsa (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Crespo, Manel (Hospital Universitari Vall d'Hebron) ; Carrillo, Jorge (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Marco, Andrés (Centre Penitenciari d'Homes (Barcelona, Catalunya)) ; Mullins, James I. (University of Washington (Estats Units d'Amèrica)) ; Dorrell, Lucy (John Radcliffe Hospital (Oxford, Regne Unit)) ; Hanke, Tomáš (University of Oxford (Regne Unit)) ; Clotet i Sala, Bonaventura (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Pavlakis, George N. (National Cancer Institute at Frederick (Frederick, Estats Units d'Amèrica)) ; Felber, Barbara K. (National Cancer Institute at Frederick (Frederick, Estats Units d'Amèrica)) ; Brander, Christian (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Universitat Autònoma de Barcelona
BACKGROUND: None of the HIV T-cell vaccine candidates that have reached advanced clinical testing have been able to induce protective T cell immunity. A major reason for these failures may have been suboptimal T cell immunogen designs. [...]
2015 - 10.1186/s12967-015-0392-5
Journal of translational medicine, Vol. 13 Núm. 60 (february 2015)  
Registro completo - Creative Commons

Vea también: autores con nombres similares
5 Hanke, Tomas
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.
Depósito Digital de Documentos de la UAB :: Buscar :: Enviar :: Personalizar :: Ayuda
Powered by Invenio v1.1.6
Mantenido por ddd.bib@uab.cat  :: Metadatos sujetos a:
Colaboramos